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We report a case of early latent syphilis (reactive serologic tests without clinical evidence of disease within 24months from the onset
of the infection) in pregnancy. Despite an appropriate maternal treatment with benzathine penicillin G, sonographic signs of fetal
syphilis were detected. Follow-up scans, in addiction to serial serological tests, have allowed the identification of fetal infection and
therefore the failure of antibiotic therapy. We highlight the importance of ultrasound in suspecting fetal infection and in evaluation
of the fetal response after penicillin treatment.
1. Introduction
Syphilis in pregnancy continues to be an important public
health problem despite the fact that laboratory investigations
and effective treatment have been well established for many
years. Penicillin is effective against Treponema pallidum and
represents the drug of choice during pregnancy. However
this treatment may not always prevent fetal infection even
when administeredwith a recommended regimen. Treatment
failure has also been reported in women treated in the first
trimester although the risk of transmission from an infected
mother to her fetus seems to be higher in pregnant women
treated during the third trimester [1]. We present a case of
congenital syphilis in which follow-up scans, in addiction to
serial serological tests, have allowed the identification of fetal
infection and therefore the failure of antibiotic therapy.
2. Case Report
A 29-year-old secundigravida Caucasian woman at 19+5
weeks of gestation was referred to our Fetal Medicine Centre
to perform a level II ultrasound scan because of positive
serology for syphilis in the first trimester.Nomaternal clinical
manifestations of disease was found on examination. She had
had a history of a feverish erythematosusmaculopapular rush
localized to trunk, limbs, palms, and soles two years before.
The diagnosis of syphilis was performed only during antena-
tal screening in the first trimester by a positive venereal dis-
ease research laboratory (VDRL) and a treponema pallidum
hemagglutination assay (TPHA) title of 1:2560. The HIV sta-
tus of the womanwas negative. Antibiotic therapywas started
immediately with benzathine penicillin G 7.2 million units
total, administered as 3 doses of 2.4 million units IM each at
1-week intervals according to the stage of syphilis, in line with
CDCguidelines. At the end of the treatment the serology tests
were stable with VDRL positive, a TPHA title of 1:2560.
The serology for syphilis also resulted positive in her
husband (VDRL positive with TPHA title of 1:320) who was
treated with a recommended regimen.
The scan performed at 19+5 weeks of gestation in our
centre revealed no abnormalities, the amniotic fluid was
found regular, and fetal growth parameters were normal.
At 23+5 weeks of gestation a follow-up scan was per-
formed and a massive hydrocephalus (Figures 1(a) and 1(b)),
severe hydrothorax, ascites, and hepatomegaly were found.
The measurement of the middle cerebral artery (MCA) was
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Figure 1: Hydrocephalus at 23+5 weeks (a and b). 2D transverse (a) and median sagittal section (b) of the fetal brain at 23+5 weeks of
gestation. These images show the massive destruction of the cerebral parenchyma and the subversion of the regular intracranial anatomy for
the impressive hydrocephalus.
performed and an increased peak systolic velocity for gesta-
tional age was found. Careful counseling with the couple was
performed after the ultrasound finding of the fetal anomaly.
Maternal blood tests for cytomegalovirus, coxsackievirus,
parvovirus, toxoplasma, and herpes virus types 1 and 2 were
found negative while syphilis serologic tests were confirmed
positive with RPR title 1:4 and TPHA title 1:640. Fetal
karyotype was normal. Further counseling was made and the
woman decided to pursue the termination of pregnancy. Fetal
autopsy showed a cutaneous erythematous papular dissemi-
nated rash, widespread edema (stronger in the limbs), ascites,
hydrothorax, internal obstructed hydrocephalus, ischemic-
haemorrhagic brain injury with disseminated lesions, pro-
ductive pachymeningitis with dystrophic calcification, hep-
atomegaly, acute hepatic and splenic hematopoiesis, produc-
tive bilateral peripyelitis, pronounced glomerulus-poiesis,
and involution of the thymus. The research of Treponema
Pallidum with coloring of Warthin-Starry identified images
compatible with the morphological appearance of the germ.
The diagnostic conclusion deposed for congenital syphilis.
3. Conclusions
Maternal syphilis remains an important cause of perinatal
morbidity and mortality. Nearly 1.5 million is the estimated
global number of pregnancies with probable active syphilis
in 2008 [2].
The vertical transmission rate is related to gestational
age, the stage of maternal infection during pregnancy, and
immunological response of the fetus [3].
Transmission of infection from maternal circulation to
the fetus through transplacental transfer of spirochetes can
occur as early as 9-10weeks of gestation although themajority
of infections in utero occur in the second trimester [4, 5].
Fetal abnormalities can be detected only after 18-20 weeks,
when the fetus starts to become immunocompetent and the
dissemination of Treponema in all fetal tissues results in a
massive inflammatory response [5].
The risk of vertical transmission is higher in the earlier
stages of the disease in the mother probably due to faster
replicative capacity of the microorganism and the highest
concentration of spirochetes in the blood circulation. Fiu-
mara reported in untreated primary and secondary syphilis a
higher risk of transmission (of 70% to 100%) than untreated
latent syphilis (40% for the early and up to 10% for the late
latent stage) [6].
If left untreated, pregnancies affected by syphilis can be
associated with adverse pregnancy outcomes such as pre-
mature and low-birth-weight infants, newborns with clinical
evidence of syphilis, early fetal loss/stillbirth, and neonatal
death [7].
Penicillin remains the treatment of choice during preg-
nancy for preventing maternal transmission to the fetus and
for treating fetal infection [8]. An antibiotic regime depends
on the stage of the maternal infection and the HIV status of
the mother. For women with early latent infection clinical
studies suggest the use of penicillin 2.4 million units IM in
a single dose. On the basis of the clinical history obtained
andphysical examination, our casewas an early latent syphilis
stage (latency within 24 months) where standard therapy
consists of administration of 2.4million units of penicillin per
week for 3 cycles [9].
In a study involving pregnant women with primary,
secondary, or early latent syphilis, treatment with a single
dose of penicillin prevented fetal infection in 98% of the cases
[8].
Patients who have been treated for late latent syphilis
showed a low serological response with a persistence of the
titers in more than 50 of cases after 5 years [6].
Early diagnosis and treatment are very important factors
in the management of syphilis during pregnancy in order
to prevent syphilis related adverse pregnancy outcomes.
However, in our case, despite the early diagnosis of syphilis
in the first trimester of pregnancy, the early latent stage of
the syphilis, and the standard antibiotic therapy immediately
administered, the obstetric outcome was adverse.
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CDC guidelines recommend a sonographic fetal evalu-
ation when syphilis is diagnosed during the second half of
pregnancy [9].
We support that all patients who have serological diag-
nosis of syphilis, at any gestational age, should perform a
sonographic fetal evaluation after 18 weeks of gestation. Serial
follow-up scans are needed to assess the evolution of the
fetal clinical conditions and the response to treatment with
penicillin.
In this case report, the first level II ultrasound did not
find any fetal abnormality. This may result in an incorrect
assumption that the antibiotic therapy had been able to
prevent maternal transmission to the fetus. Therefore we
believe that a second ultrasound should be repeated after 4
weeks from the first for an appropriate follow-up.
The most common sonographic signs of fetal syphilis
(hepatomegaly, ascites, hydrops, fetal anemia, polyhydram-
nios, and placentomegaly) are associated with a higher risk of
treatment failure [10] further with a higher risk of congenital
syphilis at delivery [11].
It was found that 12% of neonates with congenital syphilis
at birth have a normal antenatal sonographic finding [11].
Nevertheless, in a pregnancy with positive serology for
syphilis, an ultrasound scan represents a useful tool in most
cases for detecting the main fetal abnormalities caused by
congenital infection, and it allows an evaluation of fetal
response after penicillin treatment.
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